947 results on '"Rasburicase"'
Search Results
2. Mature B-Cell Lymphoma And Leukemia Study III
3. Rasburicase-induced hemolytic anemia and methemoglobinemia: a systematic review of current reports.
4. Rasburicase dose optimization for tumor lysis syndrome management in a network of community oncology practices.
5. Tumor lysis syndrome in induction therapy for acute myeloid leukemia before the rasburicase era.
6. Phase IIa Study of ALLN-346 (Engineered Urate Oxidase) in Subjects With Hyperuricemia, Gout and Chronic Kidney Disease
7. An Inpatient Study of ALLN-346 (Engineered Urate Oxidase) in Hyperuricemic Subjects (Study 201)
8. Rasburicase Treatment in Chronic Gouty Arthritis
9. Treatment with Rasburicase in Hospitalized Patients with Cardiorenal Syndrome: Old Treatment, New Scenario.
10. Treatment of Hyperuricemia With Rasburicase in Patients With Acute Lymphoblastic Leukemia or High Grade Lymphoma
11. Scintigraphy Study in Healthy Volunteers to Characterize the Performance of ALLN-346 Tablets
12. Use of rasburicase to improve kidney function in children with hyperuricemia and acute kidney injury.
13. Rasburicase in treating tumor lysis syndrome: An umbrella review
14. Tumor lysis syndrome in premature infant prompting early resection of a large sacrococcygeal teratoma: a case report
15. Evaluate the Efficacy and Safety of Rasburicase (Fasturtec®) in the Prevention and Treatment of Hyperuricemia in Pediatric Patients With Non-Hodgkin's Lymphoma and Acute Leukemia (RAISE)
16. Tolerance, Pharmacokinetics / Pharmacodynamics (PK / PD) and Immunogenicity of Pegylated Uric Acid Oxidase for Injection in Healthy Adults and Hyperuricemia Volunteers
17. Tumor lysis syndrome in premature infant prompting early resection of a large sacrococcygeal teratoma: a case report.
18. High yield expression and purification of Aspergillus flavus uricase cloned in Pichia pink™ expression system.
19. Spontaneous tumor lysis syndrome in patients with solid tumors: a scoping review of the literature.
20. Engineered Flt3L Drives Tolerogenic State to Attenuate Anti-drug Antibody Responses
21. Treatment with Rasburicase in Hospitalized Patients with Cardiorenal Syndrome: Old Treatment, New Scenario
22. TAN TOCK SENG HOSPITAL PTE LTD invites tenders for Rasburicase 1.5Mg/Ml Inj (Fasturtec)
23. SAO PAULO'S STATE GOVERNMENT invites tenders for Aq Cyclophosphamide, Calcium Polyesterine Sulphonate, Rasburicase
24. MINISTRY OF HEALTH invites tenders for Buying and Supplying Rasburicase 1.5mg Vial
25. SANOFI- PRODUTOS FARMACeUTICOS,LDA. secures contract for Purchase Of Rasburicase 1.5 Mg/ 1 Ml Inj
26. SAO PAULO'S STATE GOVERNMENT invites tenders for Aq. Cyclophosphamide, Calcium Polystyrenesulfonate, Rasburicase
27. The efficacy and cost-impact of rasburicase 3 mg versus 6 mg for the management of tumor lysis syndrome: A multicenter analysis.
28. ALLN-346 Single Ascending Dose (SAD) Study in Healthy Volunteers (SAD)
29. A Study to Determine the Safety, Tolerability, PK and Preliminary PD of SSS11 in Chinese Healthy Adult Volunteers
30. Study 102: Multiple Ascending Dose Study of ALLN-346 (Engineered Urate Oxidase) (MAD)
31. Survey of Anaphylaxis during Rasburicase Re-Administration in Patients with Hematological Malignancies Using a Japanese Claims Database
32. Supply Of The Drugs Alemtuzumab (doe), Alglucosidase Alfa (doe), Plerixafor (doe), Teriflunomide (doe) And Rasburicase (doe) For All Osakidetza Service Organizations And Linked Centers
33. Uric Acid Effects on Endothelium and Oxydative Stress
34. Rasburicase in Patients at High Risk for Tumor Lysis Syndrome (TLS) During Cycle-2
35. Survey of Anaphylaxis during Rasburicase Re-Administration in Patients with Hematological Malignancies Using a Japanese Claims Database.
36. Tumor lysis syndrome, acute kidney injury and disease-free survival in critically ill patients requiring urgent chemotherapy
37. Studies from Alborz University of Medical Sciences Update Current Data on Gene Therapy (High Yield Expression and Purification of Aspergillus Flavus Uricase Cloned In Pichia Pink & Trade; Expression System)
38. Onco-nephrology: what the intensivist needs to know
39. Successful Treatment of Acute Uric Acid Nephropathy with Rasburicase in a Primary Central Nervous System Lymphoma Patient Showing a Dramatic Response to Methotrexate—Case Report.
40. A retrospective observational study of a low fixed-dose rasburicase protocol for the treatment of tumor lysis syndrome in adults.
41. Impact of pre‐emptive rapid testing for glucose‐6‐phosphate dehydrogenase deficiency prior to rasburicase administration at a tertiary care centre: A retrospective study.
42. Use of rasburicase to improve kidney function in children with hyperuricemia and acute kidney injury
43. Effectiveness of a Single Fixed Dose of 3 mg Rasburicase for the Prevention and Management of Hyperuricemia in Tumor Lysis Syndrome in Adults With Cancer.
44. Tumor Lysis Syndrome in the Cancer Patient
45. Tumor Lysis Syndrome
46. Tumor Lysis Syndrome: Cancer Toxic Dump
47. Supply Of Nilotinib 150 Mg Tab, Factor Ix 600 Unit Inj, Darbepoietin 500 Mcg Inj, Inj Ceftazidime 2 Gm Avibactum 0 5 Gm, 3rd Generation Recombinant Factor-viii 250iu, Denosumab 120 Mg Inj, Rasburicase 1 5 Mg Inj, Recombinant Human Growth, Recuronium 10 Mg
48. Supply Of Expendable Medical Items - Tocilizumab 80mg Inj/4ml, Tocilizumab 20mg/ml 10ml Inj, Herpes Zoster Vaccine Recombinant Adjuvanted, Rasburicase 1.5 Mg Inj
49. Rasburicase induced methemoglobinemia: A systematic review of descriptive studies.
50. Acid freezes uricolysis in addition to glycolysis: Utility of fluoride-EDTA-citrate tube in the measurement of uric acid for patients administered rasburicase.
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.